Prm13 - The Flawed Recommendations of the Second Panel on Cost-Effectiveness in Health and Medicine

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2137
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost Recommendations in the Second Edition of Cost-Effectiveness in Health and Medicine: A Review

MDM Policy and Practice
Health PolicyPublic HealthOccupational HealthEnvironmental
2018English

Genomics in Medicine and Public Health: Role of Cost-Effectiveness Analysis

JAMA - Journal of the American Medical Association
Medicine
2001English

Cost-Effectiveness Calculations of Human Papillomavirus Vaccination in Punjab May Be Flawed

Cancer
Cancer ResearchOncology
2017English

Updated Recommendations for Cost-Effectiveness Studies

JAMA - Journal of the American Medical Association
Medicine
2017English

Cost-Effectiveness of the New Zealand Diabetes in Pregnancy Guideline Screening Recommendations

BMJ Open
Medicine
2015English

When Flawed Modeling Justifies Cost-Effectiveness: Making Sense of “Band-Aid” Modeling

Cancer
Cancer ResearchOncology
2018English

Cost Effectiveness Analysis of Different Health Policies Based on the Second Generation Daa-Ifn Free Regimens in an Italian Population

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Reply to Cost-Effectiveness Calculations of Human Papillomavirus Vaccination in Punjab May Be Flawed

Cancer
Cancer ResearchOncology
2017English

Cost-Effectiveness and Health Care Costs

Health Affairs
MedicineHealth Policy
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy